Felbinac

DB07477

small molecule experimental

Deskripsi

Struktur Molekul 2D

Berat 212.2439
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

149 Data
Diclofenac The risk or severity of adverse effects can be increased when Diclofenac is combined with Felbinac.
Flurbiprofen The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Felbinac.
Bromfenac The risk or severity of adverse effects can be increased when Bromfenac is combined with Felbinac.
Nepafenac The risk or severity of adverse effects can be increased when Nepafenac is combined with Felbinac.
Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Felbinac.
Nabumetone The risk or severity of adverse effects can be increased when Nabumetone is combined with Felbinac.
Tenoxicam The risk or severity of adverse effects can be increased when Tenoxicam is combined with Felbinac.
Celecoxib The risk or severity of adverse effects can be increased when Celecoxib is combined with Felbinac.
Tolmetin The risk or severity of adverse effects can be increased when Tolmetin is combined with Felbinac.
Rofecoxib The risk or severity of adverse effects can be increased when Rofecoxib is combined with Felbinac.
Piroxicam The risk or severity of adverse effects can be increased when Piroxicam is combined with Felbinac.
Fenoprofen The risk or severity of adverse effects can be increased when Fenoprofen is combined with Felbinac.
Valdecoxib The risk or severity of adverse effects can be increased when Valdecoxib is combined with Felbinac.
Sulindac The risk or severity of adverse effects can be increased when Sulindac is combined with Felbinac.
Etodolac The risk or severity of adverse effects can be increased when Etodolac is combined with Felbinac.
Mefenamic acid The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Felbinac.
Naproxen The risk or severity of adverse effects can be increased when Naproxen is combined with Felbinac.
Sulfasalazine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Felbinac.
Phenylbutazone The risk or severity of adverse effects can be increased when Phenylbutazone is combined with Felbinac.
Meloxicam The risk or severity of adverse effects can be increased when Meloxicam is combined with Felbinac.
Carprofen The risk or severity of adverse effects can be increased when Carprofen is combined with Felbinac.
Diflunisal The risk or severity of adverse effects can be increased when Diflunisal is combined with Felbinac.
Suprofen The risk or severity of adverse effects can be increased when Suprofen is combined with Felbinac.
Salicylic acid The risk or severity of adverse effects can be increased when Salicylic acid is combined with Felbinac.
Meclofenamic acid The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Felbinac.
Oxaprozin The risk or severity of adverse effects can be increased when Oxaprozin is combined with Felbinac.
Ketoprofen The risk or severity of adverse effects can be increased when Ketoprofen is combined with Felbinac.
Balsalazide The risk or severity of adverse effects can be increased when Balsalazide is combined with Felbinac.
Ibuprofen The risk or severity of adverse effects can be increased when Ibuprofen is combined with Felbinac.
Olsalazine The risk or severity of nephrotoxicity can be increased when Felbinac is combined with Olsalazine.
Lumiracoxib The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Felbinac.
Magnesium salicylate The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Felbinac.
Salsalate The risk or severity of adverse effects can be increased when Salsalate is combined with Felbinac.
Choline magnesium trisalicylate The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Felbinac.
Antipyrine The risk or severity of adverse effects can be increased when Antipyrine is combined with Felbinac.
Tiaprofenic acid The risk or severity of adverse effects can be increased when Tiaprofenic acid is combined with Felbinac.
Etoricoxib The risk or severity of adverse effects can be increased when Etoricoxib is combined with Felbinac.
Oxyphenbutazone The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Felbinac.
Niflumic acid The risk or severity of adverse effects can be increased when Niflumic acid is combined with Felbinac.
Benoxaprofen The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Felbinac.
Zomepirac The risk or severity of adverse effects can be increased when Zomepirac is combined with Felbinac.
Lornoxicam The risk or severity of adverse effects can be increased when Lornoxicam is combined with Felbinac.
Aceclofenac The risk or severity of adverse effects can be increased when Aceclofenac is combined with Felbinac.
Zaltoprofen The risk or severity of adverse effects can be increased when Zaltoprofen is combined with Felbinac.
Azapropazone The risk or severity of adverse effects can be increased when Azapropazone is combined with Felbinac.
Parecoxib The risk or severity of adverse effects can be increased when Felbinac is combined with Parecoxib.
Salicylamide The risk or severity of adverse effects can be increased when Felbinac is combined with Salicylamide.
Kebuzone The risk or severity of adverse effects can be increased when Felbinac is combined with Kebuzone.
Isoxicam The risk or severity of adverse effects can be increased when Felbinac is combined with Isoxicam.
Indoprofen The risk or severity of adverse effects can be increased when Felbinac is combined with Indoprofen.
Ibuproxam The risk or severity of adverse effects can be increased when Felbinac is combined with Ibuproxam.
Floctafenine The risk or severity of adverse effects can be increased when Felbinac is combined with Floctafenine.
Fenbufen The risk or severity of adverse effects can be increased when Felbinac is combined with Fenbufen.
Etofenamate The risk or severity of adverse effects can be increased when Felbinac is combined with Etofenamate.
Epirizole The risk or severity of adverse effects can be increased when Felbinac is combined with Epirizole.
Loxoprofen The risk or severity of adverse effects can be increased when Felbinac is combined with Loxoprofen.
Droxicam The risk or severity of adverse effects can be increased when Felbinac is combined with Droxicam.
Tolfenamic acid The risk or severity of adverse effects can be increased when Felbinac is combined with Tolfenamic acid.
Clonixin The risk or severity of adverse effects can be increased when Felbinac is combined with Clonixin.
Tepoxalin The risk or severity of adverse effects can be increased when Felbinac is combined with Tepoxalin.
Flunixin The risk or severity of adverse effects can be increased when Felbinac is combined with Flunixin.
Tinoridine The risk or severity of adverse effects can be increased when Felbinac is combined with Tinoridine.
Alclofenac The risk or severity of adverse effects can be increased when Felbinac is combined with Alclofenac.
Fentiazac The risk or severity of adverse effects can be increased when Felbinac is combined with Fentiazac.
Suxibuzone The risk or severity of adverse effects can be increased when Felbinac is combined with Suxibuzone.
Bumadizone The risk or severity of adverse effects can be increased when Felbinac is combined with Bumadizone.
Alminoprofen The risk or severity of adverse effects can be increased when Felbinac is combined with Alminoprofen.
Bufexamac The risk or severity of adverse effects can be increased when Felbinac is combined with Bufexamac.
Feprazone The risk or severity of adverse effects can be increased when Felbinac is combined with Feprazone.
Difenpiramide The risk or severity of adverse effects can be increased when Felbinac is combined with Difenpiramide.
Nifenazone The risk or severity of adverse effects can be increased when Felbinac is combined with Nifenazone.
Lonazolac The risk or severity of adverse effects can be increased when Felbinac is combined with Lonazolac.
Tenidap The risk or severity of adverse effects can be increased when Felbinac is combined with Tenidap.
Bendazac The risk or severity of adverse effects can be increased when Felbinac is combined with Bendazac.
Pranoprofen The risk or severity of adverse effects can be increased when Felbinac is combined with Pranoprofen.
Propyphenazone The risk or severity of adverse effects can be increased when Felbinac is combined with Propyphenazone.
Proglumetacin The risk or severity of adverse effects can be increased when Felbinac is combined with Proglumetacin.
Guacetisal The risk or severity of adverse effects can be increased when Felbinac is combined with Guacetisal.
Ethenzamide The risk or severity of adverse effects can be increased when Felbinac is combined with Ethenzamide.
Carbaspirin calcium The risk or severity of adverse effects can be increased when Felbinac is combined with Carbaspirin calcium.
Mofebutazone The risk or severity of adverse effects can be increased when Felbinac is combined with Mofebutazone.
Proquazone The risk or severity of adverse effects can be increased when Felbinac is combined with Proquazone.
Benorilate The risk or severity of adverse effects can be increased when Felbinac is combined with Benorilate.
Pirprofen The risk or severity of adverse effects can be increased when Felbinac is combined with Pirprofen.
Acemetacin The risk or severity of adverse effects can be increased when Felbinac is combined with Acemetacin.
Imidazole salicylate The risk or severity of adverse effects can be increased when Felbinac is combined with Imidazole salicylate.
Benzydamine The risk or severity of adverse effects can be increased when Felbinac is combined with Benzydamine.
Icosapent The risk or severity of adverse effects can be increased when Icosapent is combined with Felbinac.
Antrafenine The risk or severity of adverse effects can be increased when Antrafenine is combined with Felbinac.
Dexibuprofen The risk or severity of adverse effects can be increased when Felbinac is combined with Dexibuprofen.
Trolamine salicylate The risk or severity of adverse effects can be increased when Felbinac is combined with Trolamine salicylate.
Cimicoxib The risk or severity of adverse effects can be increased when Cimicoxib is combined with Felbinac.
Robenacoxib The risk or severity of adverse effects can be increased when Felbinac is combined with Robenacoxib.
Aminophenazone The risk or severity of adverse effects can be increased when Aminophenazone is combined with Felbinac.
Mesalazine The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Felbinac.
SC-236 The risk or severity of adverse effects can be increased when Felbinac is combined with SC-236.
NS-398 The risk or severity of adverse effects can be increased when Felbinac is combined with NS-398.
Firocoxib The risk or severity of adverse effects can be increased when Felbinac is combined with Firocoxib.
Morniflumate The risk or severity of adverse effects can be increased when Felbinac is combined with Morniflumate.
Talniflumate The risk or severity of adverse effects can be increased when Felbinac is combined with Talniflumate.

Target Protein

Prostaglandin G/H synthase 1 PTGS1
Prostaglandin G/H synthase 2 PTGS2
Procathepsin L CTSL

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 0
Belum ada data produk/brand untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field produk/brand.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul